Delivery Order SPE2DB22D3301-SPE2DB26FX4HM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Briviact 100 mg tablets (60 count) with a ceiling value of $2,943.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Briviact 100 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $2,828.45. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 4, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 50 mg tablets (60-count units) under a firm fixed-price contract valued at $2,538.23. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $2,451.23 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Briviact 50 mg tablets (60-count packages) with a ceiling value of $1,859.98. This firm fixed-price delivery order, with an ultimate completion date of May 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Briviact 100 mg tablets (60 units) with a ceiling value of $5,180.03. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,263.43 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 100 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 50mg tablets (60-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Briviact 100 mg tablets (60 count) with a ceiling value of $13,237.00. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, demonstrating the contractor's capability...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4HMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Briviact 100 mg tablets (60-count units) with a ceiling value of $2,957.36. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by November 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/4/25 |